Cellulitis

Warning

Objectives

To guide the management of patients presenting to medical facilities with suspected cellulitis / soft tissue infections.

Scope

This guideline covers the assessment and treatment of cellulitis in both adults and children within forward medical environments and in the deployed hospital environment. It includes guidance on distinguishing uncomplicated from complicated cellulitis.

Antibiotic choice should be guided by the Deployed Antimicrobial Guidance CGO.

Since resistance patterns vary widely around the world and with different nationalities, discussion with DMS Microbiology via clinical reach back is advised if initial treatment is failing. 

For advanced management of severe soft tissue infections such as necrotising fasciitis, follow the Severe Soft Tissue Infection CGO (link to follow).

Audience

This guideline is intended for the use of registered healthcare professionals fulfilling a general role in forward medical locations or in an Emergency Department on deployed operations.

Initial Assessment & Management

Clinical Features  

Localized erythema, warmth, swelling, and tenderness. Commonly affects lower limbs but may occur anywhere. May be accompanied by systemic symptoms: fever, malaise, rigors.  

 

History  

Onset and duration of symptoms.  

Recent trauma, bites, injections, surgery, tattoos, piercings or skin conditions.  

Previous episodes of cellulitis.  

Comorbidities: diabetes, peripheral vascular disease, immunosuppression.  

Recent travel or aquatic exposure (may suggest unusual pathogens).  

 

Examination  

Mark (and date) the border of erythema. If possible take photo on MedIS or similar.  

Check for systemic involvement: fever, hypotension, tachycardia.  

Assess for abscess or fluctuance. (Consider PVL infection)  

Evaluate for lymphangitis or regional lymphadenopathy.  

Check interdigital spaces for fungal infection.  

Cellulitis in special areas (face, ear, groin – see 'special presentations' in accordion content below).  

If trained and competent, consider ultrasound imaging for abscess / deep infection.

 

Assess Severity

Mild: No systemic features  

Moderate: Systemic features present but no confusion, hypotension, or immunosuppression  

Severe: significant systemic features present (e.g. acute confusion, hypotension). Treat as Necrotising Soft Tissue Infections.

 

Differential Diagnoses to consider:  

Dermatological:

Contact Dermatitis – typically very itchy, minimal pain, exposed areas

Erysipelas – Bright red, swollen, finely dimpled (like an orange)

Guttate Psoriasis – small, red, inflamed patches which later appear scaly.

Vascular:

Deep Vein Thrombosis – recent immobility, tender along veins, calf swelling

Thrombophlebitis – hard cord like vessel with distal redness

Travel / Environmental:

Cutaneous Larva Migrans – itchy, linear/serpentigious due to hookworm

Cutaneous Leishmaniasis – Painless papule becoming ulcer, slow progression

Scabies – very itchy, worse at night, 5-10mm burrows, can become generalised

Other:

Septic Joint  / Gout – single isolated red, hot joint with limited range of motion

 

Start Treatment

  1. Elevate affected limb if possible +/- application of splint immobilisation if possible and appropriate. 
  2. Address any underlying cause (e.g., tinea pedis with foot hygiene, Clotrimazole 1% TDS) 
  3. Commence antimicrobial therapy, refer to DMS Deployed Antimicrobial Guidance CGO:
    1. Mild: Oral antibiotics suitable.
    2. Moderate: Bed patient down (if able). Consider once only IV antibiotic regime. Aim for switch to oral agents after 48hrs.
    3. Severe: treat as a potential necrotizing soft tissue infection. Urgent IV antibiotics, IV fluid resuscitation, urgent surgical/orthopaedic review for consideration of necrotising fasciitis.  
If severe cellulitis / necrotising soft tissue infection is suspected, ensure: basic medical management for sepsis is delivered (IAW Immediate Management of the Septic Patient CGO - link to follow): oxygen, IV fluid resuscitation, IV antibiotics.

 

Necrotising soft tissue infections are time-critical medical emergencies. Prioritise these patients for evacuation to a setting where surgical assessment and management can be delivered as soon as possible.

 

Abscess Management  

Start antimicrobial therapy IAW the Deployed Antimicrobial Guidance CGO

If trained and competent to do so, incise and drain the abscess.   

If access to microbiology testing is available, take a swab of pus (skin swabs without pus have low diagnostic yield). Ensure that testing specifically for PVL is included in the request.

 

Adjunctive Treatments  

Analgesia and antipyretics (ibuprofen and / or paracetamol). Ibuprofen has been shown to speed resolution of redness in cellulitis as well as decrease pain.  

In patients who must return to duty urgently there is some evidence that a single dose of 60mg of oral Prednisolone speeds resolution and decreases discomfort. 

Splinting and immobilising the affected limb (if practical) can contribute to pain-management.

 

Monitoring  

Mild: Review patient in 48-72 hours and expect to see visible improvement. Reassess for any collections.   

Moderate: Review patient at 12 and 24 hours to ensure not becoming more systematically unwell. Cellulitis itself may look redder and extend slightly over the first 24 hours compared to the initial marking.   

Severe: Switch to oral therapy when clinically improving (fever & rigors gone, redness receding significantly).

 

The area of redness can be marked on the patient's skin to aid assessment of resolution/progression.

 

Complications

Abscess formation – may require incision and drainage.  

Recurrent cellulitis – consider prophylactic antibiotics for ≥2 episodes/year.  

Sepsis – early identification and management crucial. Refer to the Immediate Management of the Septic Patient CGO - link to follow

Lymphoedema – long-term complication of repeated cellulitis.  

Thrombophlebitis – especially with lower limb involvement. 

Advanced Assessment & Management

Patients attending deployed hospital settings with cellulitis should be managed in accordance with the recommendations in 'Initial Assessment & Management' above.

Patients with only mild illness generally do not require laboratory tests. In patients with signs of systemic illness, perform the following investigations in a deployed hospital setting, if available:

  • Full blood count.
  • Serum biochemistry: to include renal profile, LFTs and CRP.
  • Coagulation profile.
  • Blood cultures: perform in all patients requiring deployed hospital treatment, and in patients without systemic symptoms if atypical organisms are suspected (e.g immersion injury) or who are immunocompromised.
  • Clinical imaging (depending on availability):
    • Xray, ultrasound and MRI may all help confirm a diagnosis of osteomyelitis, local abscess or necrotising soft tissue infection. Only perform if osteomyelitis, necrotising soft tissue infection or abscess is suspected. Imaging must not delay surgical assessment.

For surgical management of soft tissue infections see the specialty-specific CGO [link to follow]. 

Prolonged Casualty Care

In some circumstances, immediate evacuation of a casualty will not be possible.  During these times, the following should be undertaken:  

  • Ensure all elements of ‘Initial Management’ (above) are undertaken.
  • Regular analgesia, including splinting and immobilisation if possible.
  • Consider thrombophrophylaxis (e.g. enoxaparin 40mg SC OD if >50kg, 20mg if <50kg, or dalteparin 5000 units SC OD) unless contraindicated - particularly if patients are immobilised.
  • Be vigilant and prepare for complications: ensure observations are monitored regularly and the cellulitic area is monitored for spread/resolution - the degree of erythema can be marked with a pen to aid serial assessment. 
  • Review the requirement for treatment escalation or step-down depending on case progression.

 

Paediatric Considerations

The principles of managing cellulitis in children are the same as for adult patients.  

 

Specific differentials to consider in the paediatric population include: 

  • Allergic/contact dermatitis: if itchy and non-tender, cellulitis is unlikely. 
  • Impetigo: well-defined lesions, often crusting, systemically well. 
  • Staphylococcal scalded skin syndrome: blistering exfoliative rash triggered by exotoxin release from Staph aureus bacteria. Rare. Predominantly seen in children under 5, with a peak onset of 2.5yrs. Usually spares the mucous membranes (unlike toxic epidermal necrolysis). A paediatric medical emergency requiring IV antibiotics and treatment in a specialist paediatric setting.
  • Septic arthritis or osteomyelitis: in young infants with erythema over a joint or bone.  
Ensure pain is adequately treated in children – refer to the analgesia CGO (link to follow)

Necrotising Soft Tissue Infections

Necrotising soft tissue infections (NSTIs) are rare but life-threatening soft tissue infections characterized by rapid necrosis of skin and subcutaneous tissues superficial to the fascia (necrotising fasciitis) or originating deep to the fascia and primarily affecting the muscles (necrotising myositis). Early identification is critical as delays in treatment significantly increase mortality.  

 

Clinical Features  

Severe, rapidly worsening pain out of proportion to physical findings.  

Skin may appear erythematous, tense, shiny; later stages show blistering, dusky discoloration, or necrosis. Loss of sensation is a late sign, correlating with destruction of the sensory nerves supplying that area of skin. 

Systemic signs: fever, tachycardia, hypotension, confusion.  

Crepitus or subcutaneous gas may be palpable.  

Rapidly progressing redness despite treatment  

 

Risk Factors  

Diabetes mellitus  

Immunosuppression – often non-specific viral illness in the preceding days / weeks. 

Recent surgery or trauma  

Injecting drug use  

Chronic wounds or ulcers  

 

Investigations  

LRINEC score may support clinical suspicion but for such a high mortality condition only has a pooled sensitivity of 50% and constituent lab tests are not available in many forward medical settings. 

Do not use LRINEC score if there is a high suspicion of necrotising fasciitis and use only with caution in all other patients: 10% of patients in the original observational study with necrotising fasciitis still had a LRINEC score <6, and there have been no subsequent prospective trials validating the LRINEC score. 

LRINEC score:

  • 4 points if CRP > 15
  • 1 point if WCC > 15; 2 points if > 25
  • 1 point if Hb < 13.5; 2 points if < 11
  • 2 points is Na < 135
  • 2 points if creatinine > 141
  • 1 point if glucose > 10

LRINEC ≥ 6 is a reasonable rule-in but LRINEC < 6 does not rule out.  

Imaging (CT/MRI) can help but must not delay surgical referral. In most deployed environments is unlikely to be available.  

 

Management  

Immediate surgical consultation.   

Immediate administration of Broad-spectrum IV antibiotics as per DMS antimicrobial guidance  

Supportive care for sepsis and multi-organ dysfunction. See Sepsis CGO (insert link later)

Panton-Valentine Leukocidin (PVL)

Panton-Valentine Leukocidin is a toxin produced by some strains of Staphylococcus aureus, often associated with more aggressive skin and soft tissue infections. PVL is linked to recurrent boils, abscesses, and in rare cases, severe necrotizing pneumonia.  

 

Clinical Features  

Frequently presents with painful, erythematous, and fluctuant skin lesions.  

May cause rapid progression to necrosis in severe cases.  

Recurrent or familial cases of boils or abscesses should raise suspicion of PVL-producing strains.  

 

Assessment  

As above. If microbiology testing is available, send pus swab with ?PVL in clinical question section.  

 

Management  

Incision and drainage remain the mainstay for localized abscesses.  

Antibiotic therapy should be guided by local resistance patterns and microbiology results, with agents effective against PVL-producing S. aureus (e.g., doxycycline, clindamycin).  

Strict adherence to personal hygiene, avoiding sharing of towels and other personal items, and wiping down of communal items such as gym equipment are important messages to share via the chain of command to limit spread.

Decolonization / suppression therapy for recurrent cases or household outbreaks is recommended. This includes nasal mupirocin and chlorhexidine body washes. JSP 950 Leaflet 7-2-9 (available on MODNET) provides in depth guidance on suspected PVL in primary care. Seek advice from Public Health as definition of household contact in the deployed setting can be nuanced.

 

Considerations  

PVL-related infections require heightened awareness for early identification and appropriate treatment to prevent complications.  

Pre-septal and Orbital Cellulitis

Pre-septal (peri-orbital): Infection anterior to orbital septum. Presents with eyelid erythema, oedema, but no visual impairment or pain with eye movement.  

Orbital cellulitis: Posterior to septum. May cause proptosis, painful or restricted eye movement, vision changes, or ophthalmoplegia.  

See CGO on pre-septal and orbital cellulitis for full details on assessment and management.

Auricular Cellulitis / Perichondritis

Involves pinna and surrounding tissues, often secondary to trauma, piercings, or otitis externa. Perichondritis, spares the earlobe and affects cartilage.  

 

Assessment  

Look for erythema, swelling, warmth of ear.  

Assess for pain, discharge, and signs of cartilage involvement.  

Examine mastoid and check for fluctuance, tenderness or oedema in case of mastoiditis.  

Examine ear canal checking for posterior canal bulging (mastoiditis), otitis externa or media.  

 

Management  

Mild: Oral antibiotics.  

Moderate/severe or cartilage involvement: IV antibiotics; ENT discussion via MedIS if able.  

Consider Pseudomonas coverage in swimmers or immunocompromised.  

If fluctuance of pinna present and then left untreated, the abscess will cause cartilage collapse and poor cosmetic appearance. Drainage of the abscess will be required to try and prevent this. 

If otitis externa present treat in addition.

Fournier’s Gangrene

A rapidly progressing, life-threatening necrotizing soft tissue infection of the perineum and genitals.  

 

Clinical Features  

Severe pain in genital/perineal area, swelling, erythema, often with crepitus.  

Skin may progress to dusky, necrotic appearance.  

Systemic toxicity is usually present (fever, hypotension, tachycardia).  

 

Risk Factors  

Diabetes mellitus  

Alcoholism  

Immunocompromised states  

Urogenital or anorectal infections  

 

Management  

Emergency general surgical referral — requires urgent debridement.  

Immediate administration of Broad-spectrum IV antibiotics as per guidance  

Intensive supportive care including fluid resuscitation  

Consider transfer to specialist centre with intensive care, plastics and urology for longer term care

Last reviewed: 03/07/2026

Next review date: 03/07/2027

References

BMJ Best Practice (2023) Cellulitis and erysipelas. BMJ Publishing Group. https://bestpractice.bmj.com/info

NICE (2025) Cellulitis CKS. Cellulitis - acute | Health topics A to Z | CKS | NICE

Evidence method

Consensus guideline.